首页> Annals of the American Thoracic Society> Does 'super-responder' patients to cardiac resynchronization therapy still have indications for neuro-hormonal antagonists? Evidence from long-term follow-up in a single center

Does 'super-responder' patients to cardiac resynchronization therapy still have indications for neuro-hormonal antagonists? Evidence from long-term follow-up in a single center

导出原文传递

翻译打印收藏纠错

第一作者： Hu, Yi-Ran

作者： Hu, Yi-Ran ^[1] ; Hua, Wei ; Jin, Han ; Gu, Min ; Fan, Xiao-Han ; Niu, Hong-Xia ; Ding, Li-gang ; Wang, Jing ; Zhang, Shu

作者单位： Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Fuwai Hosp,Cardiac ^[1]

关键词 Cardiac resynchronization therapy Heart failure Super-responder Optimal medical therapy

发布时间 2020-08-13

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Annals of the American Thoracic Society

2019年16卷3期

251-258页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

Annals of the American Thoracic Society

2019年16卷3期

251-258页

检索历史清除

Does 'super-responder' patients to cardiac resynchronization therapy still have indications for neuro-hormonal antagonists? Evidence from long-term follow-up in a single center

Annals of the American Thoracic Society

相似文献

同项目论文

Annals of the American Thoracic Society

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Does 'super-responder' patients to cardiac resynchronization therapy still have indications for neuro-hormonal antagonists? Evidence from long-term follow-up in a single center

Annals of the American Thoracic Society

相似文献

同项目论文

Annals of the American Thoracic Society

相关期刊

检索历史清除